Newsletter September 2023 No.217

Top News

The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum" Drug Resistance (AMR) Action Plan 2023-2027 - Key Points and Future Responses - (Japanese only)

The Global Health Subcommittee of the International Committee of the Pharmaceutical Manufacturers Association of Japan (PMAJ) held a media forum on June 28, 2023, at the Belle Salle Tokyo Nihonbashi in Tokyo to promote the development of new antimicrobial agents against drug resistance (Antimicrobial Resistance, AMR) in Japan. On June 28, 2023, the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum was held at Bellesalle Tokyo Nihonbashi (Chuo-ku, Tokyo). Nineteen media representatives from 15 companies participated in the forum, both on-site and online.

Topics

Policy Research Institute page

Approval Status of Drugs for Unmet Medical Needs

From JPMA

Toward Strengthening Japan's Drug Discovery Capability

Information

Share this page

TOP